Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Nidal Muvarak"'
Autor:
Nidal Muvarak, Haishan Li, Tyler Lahusen, Jeffrey A. Galvin, Princy N. Kumar, C. David Pauza, José Bordon
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
The cell and gene therapy product AGT103-T was designed to restore the Gag-specific CD4+ T cell response in persons with chronic HIV disease who are receiving antiretroviral therapy. This autologous, genetically engineered cell product is under inves
Externí odkaz:
https://doaj.org/article/47927a7ea0e545aeb40b3354b73168e0
Autor:
Haishan Li, Tyler Lahusen, Lingzhi Xiao, Nidal Muvarak, Jana Blazkova, Tae-Wook Chun, C. David Pauza
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 1048-1060 (2020)
Activation, infection, and eventual depletion of human immunodeficiency virus (HIV)-specific cluster of differentiation 4 (CD4) T cells are the crucial pathogenetic events in acquired immunodeficiency syndrome (AIDS). We developed a cell and gene the
Externí odkaz:
https://doaj.org/article/537a7b1f723a4249a33ac8a83b49f5da
Autor:
Rena G. Lapidus, Brandon A. Carter-Cooper, Mariola Sadowska, Eun Yong Choi, Omasiri Wonodi, Nidal Muvarak, Karthika Natarajan, Lakshmi S. Pidugu, Anil Jaiswal, Eric A. Toth, Feyruz V. Rassool, Arash Etemadi, Edward A. Sausville, Maria R. Baer, Ashkan Emadi
Publikováno v:
Pharmaceuticals, Vol 9, Iss 1, p 4 (2016)
Selective targeting of the oxidative state, which is a tightly balanced fundamental cellular property, is an attractive strategy for developing novel anti-leukemic chemotherapeutics with potential applications in the treatment of acute myeloid leukem
Externí odkaz:
https://doaj.org/article/9e1d3d412caa48ea961cdee4faf734f5
Autor:
Feyruz V. Rassool, Kara Scheibner, Curt Civin, Carlo Gambacorti-Passerini, Danilo Perrotti, Maria R. Baer, Carine Robert, Shannon Kelley, Nidal Muvarak
FIGURE S4. Western blots for PARP1, LIG3 and c-MYC proteins and MO7e-BCR-ABL1 cells; Flow cytometric data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298e87036a275b13223e486552ed5d94
https://doi.org/10.1158/1541-7786.22514287
https://doi.org/10.1158/1541-7786.22514287
Autor:
Feyruz V. Rassool, Kara Scheibner, Curt Civin, Carlo Gambacorti-Passerini, Danilo Perrotti, Maria R. Baer, Carine Robert, Shannon Kelley, Nidal Muvarak
Table S2. Predicted C-MYC-regulated MicroRNA Binding Sites in the Coding Region and 3'UTR of LIG3 and PARP1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb2800eaeb65947ca6d362a7a887df5
https://doi.org/10.1158/1541-7786.22514281
https://doi.org/10.1158/1541-7786.22514281
Autor:
Tae-Wook Chun, Lingzhi Xiao, C. David Pauza, Jana Blazkova, Tyler Lahusen, Haishan Li, Nidal Muvarak
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 1048-1060 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Activation, infection, and eventual depletion of human immunodeficiency virus (HIV)-specific cluster of differentiation 4 (CD4) T cells are the crucial pathogenetic events in acquired immunodeficiency syndrome (AIDS). We developed a cell and gene the
Publikováno v:
Current Hematologic Malignancy Reports. 7:94-102
Philadelphia positive (Ph+) chronic myeloid leukemia (CML) is characterized by the occurrence of nonrandom genetic and cytogenetic abnormalities during disease progression. Many of these abnormalities are markers for genes which, when altered, can dr
Autor:
Brandon Carter-Cooper, Rena G. Lapidus, Maria R. Baer, Arash Etemadi, Edward A. Sausville, Omasiri Wonodi, Eric A. Toth, Nidal Muvarak, Karthika Natarajan, Feyruz V. Rassool, Eun Yong Choi, Ashkan Emadi, Lakshmi S. Pidugu, Anil K. Jaiswal, Mariola Sadowska
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 9, Iss 1, p 4 (2016)
Pharmaceuticals; Volume 9; Issue 1; Pages: 4
Pharmaceuticals, Vol 9, Iss 1, p 4 (2016)
Pharmaceuticals; Volume 9; Issue 1; Pages: 4
Selective targeting of the oxidative state, which is a tightly balanced fundamental cellular property, is an attractive strategy for developing novel anti-leukemic chemotherapeutics with potential applications in the treatment of acute myeloid leukem
Autor:
Stephen B. Baylin, Khadiza Chowdhury, Maria R. Baer, Yi Cai, Xia Limin, Nidal Muvarak, Carine Robert, Feyruz V. Rassool, Marina A. Bellani, Eun Yong Choi, Rena G. Lapidus, Michael M. Seidman
Publikováno v:
Cancer Research. 77:IA13-IA13
Poly (ADP-ribose) polymerase (PARP) inhibitors represent one of the most exciting recent developments in cancer therapy. While substantial efficacy has been shown with clinically available PARP inhibitors (PARPis), to date, in treatment of hereditary
Autor:
Masayuki Endo, Sheng-Yu Jin, Wenjing Cao, Philip W. Zoltick, Nidal Muvarak, Christopher G. Skipwith, Alan W. Flake, Masami Niiya, Dezhi Shang, X. Long Zheng, David G. Motto
Publikováno v:
Molecular Therapy. 17(1):34-41
Deficiency of A Disintegrin And Metalloprotease with ThromboSpondin (ADAMTS13) results in thrombotic thrombocytopenic purpura (TTP). Plasma infusion or exchange is the only effective treatment to date. We show in this study that an administration of